The stock of Alector Inc (NASDAQ: ALEC) has increased by 12.50 when compared to last closing price of 1.04.Despite this, the company has seen a loss of -10.00% in its stock price over the last five trading days. globenewswire.com reported 2025-05-08 that Topline data from pivotal INFRONT-3 Phase 3 clinical trial of latozinemab in FTD-GRN on track for Q4 2025 Completed enrollment in PROGRESS-AD Phase 2 clinical trial of AL101 in early Alzheimer’s disease Continuing to pursue Alector Brain Carrier programs, including the company’s anti-amyloid beta antibody and its GCase enzyme replacement therapy Extending runway into the second half of 2027, with $354.6 million in cash, cash equivalents, and investments SOUTH SAN FRANCISCO, Calif., May 08, 2025 (GLOBE NEWSWIRE) — Alector, Inc. (Nasdaq: ALEC), a late-stage clinical biotechnology company focused on developing therapies to counteract the devastating progression of neurodegeneration, today reported first quarter 2025 financial results and recent portfolio and business updates.
Is It Worth Investing in Alector Inc (NASDAQ: ALEC) Right Now?
The 36-month beta value for ALEC is also noteworthy at 0.66. There are mixed opinions on the stock, with 5 analysts rating it as a “buy,” 1 rating it as “overweight,” 1 rating it as “hold,” and 1 rating it as “sell.”
The public float for ALEC is 75.59M, and at present, short sellers hold a 7.09% of that float. The average trading volume of ALEC on May 12, 2025 was 761.30K shares.
ALEC’s Market Performance
ALEC’s stock has seen a -10.00% decrease for the week, with a 19.46% rise in the past month and a -33.14% fall in the past quarter. The volatility ratio for the week is 11.31%, and the volatility levels for the past 30 days are at 9.82% for Alector Inc The simple moving average for the past 20 days is 6.74% for ALEC’s stock, with a -62.67% simple moving average for the past 200 days.
Analysts’ Opinion of ALEC
Many brokerage firms have already submitted their reports for ALEC stocks, with Mizuho repeating the rating for ALEC by listing it as a “Neutral.” The predicted price for ALEC in the upcoming period, according to Mizuho is $2.50 based on the research report published on December 17, 2024 of the previous year 2024.
Stifel, on the other hand, stated in their research note that they expect to see ALEC reach a price target of $4. The rating they have provided for ALEC stocks is “Hold” according to the report published on December 16th, 2024.
BofA Securities gave a rating of “Underperform” to ALEC, setting the target price at $1 in the report published on December 04th of the previous year.
ALEC Trading at -3.99% from the 50-Day Moving Average
After a stumble in the market that brought ALEC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -82.74% of loss for the given period.
Volatility was left at 9.82%, however, over the last 30 days, the volatility rate increased by 11.31%, as shares surge +29.38% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -29.52% lower at present.
During the last 5 trading sessions, ALEC fell by -10.00%, which changed the moving average for the period of 200-days by -82.22% in comparison to the 20-day moving average, which settled at $1.0961. In addition, Alector Inc saw -38.10% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ALEC starting from Kenkare-Mitra Sara, who sale 29,073 shares at the price of $1.47 back on Mar 03 ’25. After this action, Kenkare-Mitra Sara now owns 536,142 shares of Alector Inc, valued at $42,662 using the latest closing price.
Rosenthal Arnon, the Chief Executive Officer of Alector Inc, sale 40,330 shares at $1.47 during a trade that took place back on Mar 03 ’25, which means that Rosenthal Arnon is holding 2,466,744 shares at $59,176 based on the most recent closing price.
Stock Fundamentals for ALEC
Current profitability levels for the company are sitting at:
- -1.44 for the present operating margin
- 0.93 for the gross margin
The net margin for Alector Inc stands at -1.18. The total capital return value is set at -0.42. Equity return is now at value -90.26, with -23.65 for asset returns.
Based on Alector Inc (ALEC), the company’s capital structure generated 0.25 points at debt to capital in total, while cash flow to debt ratio is standing at -5.41.
Currently, EBITDA for the company is -136.16 million with net debt to EBITDA at -0.07. When we switch over and look at the enterprise to sales, we see a ratio of 1.26. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.34.
Conclusion
In summary, Alector Inc (ALEC) has had a bad performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
